Authors: Audrey Dionne, MD1,2; Francesca Sperotto, MD1,2; Stephanie Chamberlain1,2; et alAnnette L. Baker, MSN, CPNP1,2; Andrew J. Powell, MD1,2; Ashwin Prakash, MD1,2; Daniel A. Castellanos, MD1,2; Susan F. Saleeb, MD1,2; Sarah D. de Ferranti, MD, MPH1,2; Jane W. Newburger, MD, MPH1,2; Kevin G. Friedman, MD1,2 JAMA Cardiol. 2021;6(12):1446-1450. doi:10.1001/jamacardio.2021.347 Question What are the findings on cardiac imaging in children with myocarditis after COVID-19 […]
Study: Myocarditis risk 37 times higher for children with COVID-19 than uninfected peers
Authors: Melissa Jenco, News Content Editor August 31, 2021 The risk of myocarditis for children under 16 years is 37 times higher for those infected with COVID-19 than those who […]
The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development
Authors: Jiong Wang andMartin S. Zand Published online by Cambridge University Press: 13 April 2020 Journal of Clinical and Translational Science>Volume 5 Issue 1 Abstract There is an urgent need for vaccines […]
Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19
Authors: Stephanie Seneff1 and Greg Nigh Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge MA, 02139, USA, E- Naturopathic Oncology, Immersion Health, Portland, OR 97214, ABSTRACT Operation Warp Speed brought […]
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
Authors: Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent & Brandon J. DeKosky Nature Microbiology volume 5, pages1185–1191 (2020) Abstract Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through […]
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Authors: Gabriela Athziri Sánchez-Zuno,1,†Mónica Guadalupe Matuz-Flores,1,†Guillermo González-Estevez,1Ferdinando Nicoletti,2Francisco Javier Turrubiates-Hernández,1Katia Mangano,2 and José Francisco Muñoz-Valle1 Int J Immunopathol Pharmacol. 2021 Jan-Dec; 35: 20587384211050199.Published online 2021 Oct 10. doi: 10.1177/20587384211050199PMCID: PMC8512237PMID: 34632844 Abstract The coronavirus disease 2019 (COVID-19) […]
Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health
Authors: DAVID GORTLER FEBRUARY 10, 2022 Manufacturers, FDA, and CDC must investigate serious cardiovascular incidents related to the Pfizer and Moderna Covid vaccines. From day ,one the U.S. Food and […]
Long-term cardiovascular outcomes of COVID-19
Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly Nature Medicine (2022) Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not […]
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021
Weekly / January 28, 2022 / 71(4);125–131 January 19, 2022, this report was posted online as an MMWR Early Release. Authors: Tomás M. León, PhD1; Vajeera Dorabawila, PhD2; Lauren Nelson, MPH1; Emily Lutterloh, […]
1000 Peer Reviewed Studies Questioning Covid-19 Vaccine Safety
Peer Reviewed Medical Papers Submitted To Various Medical Journals, Evidencing A Multitude Of Adverse Events In Covid-19 Vaccine Recipients. The list includes studies published as of January 20, 2022 concerning […]